Loading...

Global Protein Consumption And Natural Health Will Fuel Expansion

Published
12 Sep 24
Updated
27 Aug 25
AnalystConsensusTarget's Fair Value
US$28.75
14.2% undervalued intrinsic discount
10 Sep
US$24.66
Loading
1Y
-20.7%
7D
1.0%

Author's Valuation

US$28.7514.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on27 Aug 25
Fair value Decreased 11%

Analysts have raised Hormel Foods’ price target modestly to $33.00, citing improved earnings outlook from Planters, stabilized turkey supply, ongoing cost savings, and attractive valuation supporting resilient long-term growth. Analyst Commentary Bullish analysts expect a recovery in Hormel’s earnings outlook, driven by improvements in the Planters business and a stabilized turkey supply situation.

Shared on07 May 25
Fair value Increased 1.36%

Shared on30 Apr 25
Fair value Increased 0.094%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 1.88%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.35%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 2.54%

AnalystConsensusTarget has increased revenue growth from 1.8% to 2.7%.